Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
about
Routes of administration of antibiotic prophylaxis for preventing infection after caesarean sectionRoutes of administration of antibiotic prophylaxis for preventing infection after caesarean section'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data.WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension: a NICE Medical Technology Guidance.A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: sorafenib for second line renal cell cancer.Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway.Incorporating quality of evidence into decision analytic modeling.Risk factors for surgical site infection after low transverse cesarean section.Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristicsCost-effectiveness of sorafenib compared to best supportive care in second line renal cell cancer from a payer perspective in Cyprus.A Bayesian approach to net health benefits: an illustration and application to modeling HIV prevention.
P2860
Q24187474-85867E88-678D-4B12-8826-0C6F84B003A5Q26471464-C64F22D1-2D44-4885-8780-3DFE0A5F1843Q33261643-AA8BB690-8848-4A9A-9EA7-A52BE62C98ECQ33633748-9EFD8874-2458-4D86-A448-8BF309DD64BAQ33646171-FC46138B-319F-4209-87D3-21D93D9BCF03Q35098611-FBF6FAC0-A3B0-436B-ADE3-9618149919FEQ36285963-9F0C80B6-6F71-4E2B-B9E8-E39E95890920Q37176410-D5FE60E2-2B3E-442A-B854-0E1DA474F00EQ41413446-58130609-EB6E-4A0F-B31D-E0FDBB008C3AQ42636265-15A87DA7-A824-42CA-9A75-8D4EFFD9B56FQ51984621-A3242D8A-F4D8-4700-A5B2-039E38BBC8F3
P2860
Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Decision analytical economic m ...... ics use for caesarean section.
@ast
Decision analytical economic m ...... ics use for caesarean section.
@en
type
label
Decision analytical economic m ...... ics use for caesarean section.
@ast
Decision analytical economic m ...... ics use for caesarean section.
@en
prefLabel
Decision analytical economic m ...... ics use for caesarean section.
@ast
Decision analytical economic m ...... ics use for caesarean section.
@en
P2860
P1476
Decision analytical economic m ...... tics use for caesarean section
@en
P2093
A J Sutton
N J Cooper
P2860
P304
P356
10.1191/0962280202SM306RA
P577
2002-12-01T00:00:00Z